Trial Information
Eight Week Plant-based Mediterranean Diet as Prevention of Metabolic Syndrome in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer: A BrUOG Pilot Study
Primary Objective: To assess for changes in the following measurements after 8 weeks of
following a Mediterranean diet-- LDL, HDL, TG, FBS, creatinine, serum testosterone,
triglycerides, serum insulin, CRP, 1bs, Waist circumference, blood pressure, body weight
Inclusion Criteria:
- Histologically documented carcinoma of the prostate
- On treatment with androgen deprivation therapy for at least 3 months
- Required laboratory values:
- Serum creatinine less than 2.5
- Triglycerides <300
- Fasting glucose < 126
- Testosterone level <50
Exclusion Criteria:
- No diabetes mellitus (Type 1 or 2)
- No renal failure (Serum creatinine > 2.5)
- No active cardiac disease -no history of myocardial infarction/stroke within the last
12 months, no recurrent unstable angina, uncontrolled/unstable arrhythmias,
uncontrolled hypertension (systolic blood pressure >160, diastolic blood pressure
>100)
- No severe peripheral vascular disease
- No commencement of lipid lowering agent within 8 weeks of enrollment the study or
change in dose throughout the study
Type of Study:
Interventional
Study Design:
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Outcome Measure:
To assess changes in the blood chemistry levels after 8 weeks of following a Mediterranean diet
Outcome Time Frame:
eight weeks
Safety Issue:
No
Principal Investigator
Anthony Mega, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
The Miriam Hospital
Authority:
United States: Institutional Review Board
Study ID:
BrUOG-MED/PROS-219
NCT ID:
NCT01083771
Start Date:
February 2009
Completion Date:
August 2012
Related Keywords:
- Prostate Cancer
- Prostatic Neoplasms
- Metabolic Syndrome X